H2

H2 EBITDA per Employee

The EBITDA per Employee of H2 (7851.TWO) as of Oct 16, 2026 is -1.05 M TWD. In the previous year, EBITDA per Employee was -996,650.68 TWD — a change of 5.65% (lower).

EBITDA per Employee

-1.05 MTWD

YoY

5.65%

Last updated:

EBITDA per Employee of H2 is 2024 -1.05 M TWD. EBITDA per Employee of H2 was 2023 -996,650.68 TWD. It decreases by 5.65% lower compared to the previous year.

The H2 EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2023
-996,650.68 TWD
Jan 1, 2024
-1.05 M TWD
The H2 EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-1.05 MTWD+5.65%
-996,650.68TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

H2 Stock analysis

What does H2 do? H2 Inc is a company based in George Town, Grand Cayman, operating in the healthcare technology sector. The company employs 146 full-time staff and is set to undergo an initial public offering (IPO) on November 19, 2025. H2 Inc provides personalized healthcare solutions through data analytics, focusing on patient-centered care. The company's offerings include a mobile application and a patient management platform, both designed to support chronic disease management. The Health2Sync App enables users to record health data, track long-term trends, review historical information, and share reports with healthcare providers. It also offers reminder features and care coordination with partner organizations. A premium membership tier provides enhanced data analysis and educational resources. The Patient Management Platform facilitates rapid deployment, patient prioritization, data-driven insights, and improved communication channels. The company supports integration with various health monitoring devices and applications, including blood glucose meters, blood pressure monitors, weight scales, insulin pens, continuous glucose monitors (CGMs), and compatible health apps. H2 Inc's technology aims to streamline healthcare management for individuals with chronic conditions through digital tools and data synchronization. The company's headquarters are located in George Town, Grand Cayman, and it operates under the ticker symbol 7851.TWO with ISIN KYG4711S1030. The company's website is https://www.health2sync.com/. H2 is one of the most popular companies on Eulerpool.

Frequently Asked Questions about H2 stock

EBITDA per Employee of H2 is -1.05 M TWD in 2024.

EBITDA per Employee of H2 changed from -996,650.68 TWD to -1.05 M TWD, representing a 5.65% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee H2 since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's H2 historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — H2

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — H2